Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.7 (
DNA polymerase
)
17,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hematoporphyrin derivative
(
HPD
) plus photoradiation caused the inactivation of DNA polymerases from calf thymus and R3230AC rat mammary tumor. Photosensitization of purified DNA polymerase-alpha as well as two forms of
DNA polymerase
-delta (I and II) from calf thymus were evaluated. Although all polymerase enzyme forms were inactivated at 70 micrograms
HPD
/ml,
DNA polymerase
-delta II was the most sensitive, displaying a 90% inactivation under conditions that did not cause significant inactivation of the other polymerase forms. Unlike DNA polymerase-alpha, the delta-forms have an associated 3'- to 5'-exonuclease activity. The exonuclease associated with
DNA polymerase
-delta II was uniquely sensitive to a low level of
HPD
and light exposure.
DNA polymerase
-delta II can be distinguished from other polymerase forms in cell extracts by its relative insensitivity to the polymerase inhibitor N2-(p-n-butylphenyl)deoxyadenosine 5'-triphosphate. In cytosols prepared from calf thymus and R3230AC rat mammary tumors,
DNA polymerase
-delta II was preferentially inhibited by
HPD
plus light. Furthermore, in experiments in which tumor-bearing rats were administered
HPD
prior to preparation of tumor cytosols,
DNA polymerase
-delta II was specifically inactivated by exposure to light. These results are discussed in view of their possible role in cancer therapy, and the potential use of
HPD
as a specific inhibitory agent of
DNA polymerase
-delta II is suggested.
...
PMID:Inhibition of mammalian DNA polymerases by hematoporphyrin derivative and photoradiation. 394 Jan 88